Molecular pathological analysis of sarcomas using paraffin-embedded tissue: Current limitations and future possibilities

Histopathology

Volumn 64, Issue 1, 2014, Pages 163-170

  van de Rijn, Matt ^a   Guo, Xiangqian ^a   Sweeney, Robert T ^a   Beck, Andrew H ^b   West, Robert B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Molecular testing; Next generation sequencing; Sarcoma

Indexed keywords

DNA; MESSENGER RNA; PARAFFIN;

CLEAR CELL SARCOMA; DNA DETERMINATION; ENDOMETRIUM SARCOMA; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN GENOME; LEIOMYOSARCOMA; LIPOSARCOMA; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE; SARCOMA; SOFT TISSUE SARCOMA; TUMOR DIAGNOSIS;

MOLECULAR TESTING; NEXT-GENERATION SEQUENCING; SARCOMA;

GENE EXPRESSION PROFILING; HUMANS; PARAFFIN EMBEDDING; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 84889666430     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12290     Document Type: Review

References (30)

1. Neuville A, Ranchère-Vince D, Dei Tos AP et al. Impact of molecular analysis on the final sarcoma diagnosis. Am. J. Surg. Pathol. 2013; 37; 1259-1268.
2. Spencer DH, Sehn JK, Abel HJ, Watson MA, Pfeifer JD, Duncavage EJ. Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens. J. Mol. Diagn. 2013; 15; 623-633.
3. Nielsen TO, West RB. Translating gene expression into clinical care: sarcomas as a paradigm. J. Clin. Oncol. 2010; 28; 1796-1805.
4. Demicco EG, Lazar AJ. Clinicopathologic considerations: how can we fine tune our approach to sarcoma? Semin. Oncol. 2011; 38(Suppl. 3); S3-S18.
5. Fisher C. Current aspects of the pathology of soft tissue sarcomas. Semin. Radiat. Oncol. 1999; 9; 315-327.
6. Lee C-H, Ou WB, Marino-Enriquez A et al. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc. Natl Acad. Sci. USA 2012; 109; 929-934.
7. Lee C-H, Mariño-Enríquez A, Ou W et al. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas. Am. J. Surg. Pathol. 2012; 36; 641-653.
8. Jin Y, Möller E, Nord KH et al. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosom. Cancer 2012; 51; 510-520.
9. Chmielecki J, Crago AM, Rosenberg M et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat. Genet. 2013; 45; 131-132.
10. Erickson-Johnson MR, Chou MM, Evers BR et al. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab. Invest. 2011; 91; 1427-1433.
11. West RB, Rubin BP, Miller MA et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc. Natl Acad. Sci. USA 2006; 103; 690-695.
12. Cupp JS, Miller MA, Montgomery KD et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am. J. Surg. Pathol. 2007; 31; 970-976.
13. Oliveira AM, Perez-Atayde AR, Inwards CY et al. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am. J. Pathol. 2004; 165; 1773-1780.
14. Oliveira AM, Chou MM. USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum. Pathol. 2013; pii: S0046-8177(13)00116-0. doi: 10.1016/j.humpath.2013.03.005. [Epub ahead of print].
15. Mehine M, Kaasinen E, Mäkinen N et al. Characterization of uterine leiomyomas by whole-genome sequencing. N. Engl. J. Med. 2013; 369; 43-53.
16. Ordonez JL, Osuna D, Herrero D, de Alava E, Madoz-Gúrpide J. Advances in Ewing's sarcoma research: where are we now and what lies ahead? Cancer Res. 2009; 69; 7140-7150.
17. Pollack JR, Sørlie T, Perou CM et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl Acad. Sci. USA 2002; 99; 12963-12968.
18. Linn SC, West RB, Pollack JR et al. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Am. J. Pathol. 2003; 163; 2383-2395.
19. Beck AH, Weng Z, Witten DM et al. 3′-End sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One 2010; 5; e8768.
20. Lee C-H, Ali RH, Rouzbahman M et al. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am. J. Surg. Pathol. 2012; 36; 1562-1570.
21. West RB, Nuyten DSA, Subramanian S et al. Determination of stromal signatures in breast carcinoma. PLoS Biol. 2005; 3; e187.
22. Beck AH, Espinosa I, Gilks CB, van de Rijn M, West RB. The fibromatosis signature defines a robust stromal response in breast carcinoma. Lab. Invest. 2008; 88; 591-601.
23. Beck AH, Espinosa I, Edris B et al. The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin. Cancer Res. 2009; 15; 778-787.
24. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012; 81; 145-166.
25. Brunner AL, Beck AH, Edris B et al. Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol. 2012; 13: R75. [Epub ahead of print].
26. Sweeney RT, Zhang B, Zhu SX et al. Desktop transcriptome sequencing from archival tissue to identify clinically relevant translocations. Am. J. Surg. Pathol. 2013; 37; 796-803.
27. Newburger DE, Kashef-Haghighi D, Weng Z et al. Genome evolution during progression to breast cancer. Genome Res. 2013; 23; 1097-1108.
28. Beltran H, Yelensky R, Frampton GM et al. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity. Eur. Urol. 2013; 63; 920-926.
29. Kerick M, Isau M, Timmermann B et al. Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med. Genomics 2011; 4; 68-80.
30. Schweiger MR, Kerick M, Timmermann B et al. Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS One 2009; 4; e5548.